Company Filing History:
Years Active: 1986-1995
Title: Allen H Pekar: Innovator in Diabetes Treatment
Introduction
Allen H Pekar is a notable inventor based in Indianapolis, IN (US), recognized for his contributions to diabetes treatment through innovative formulations. He holds a total of 4 patents, showcasing his commitment to advancing medical science.
Latest Patents
Among his latest patents, Pekar has developed insulin analog formulations that disclose a human insulin analog hexamer complex. This invention relates to various parenteral formulations that include human insulin analogs in a hexamer conformation, zinc ions, and phenolic derivatives such as m-cresol and phenol. The formulation is designed to provide a rapid onset of action, which is crucial for effective diabetes management. Additionally, he has described a class of anti-diabetic compounds that exhibit insulin-like activity, further enhancing treatment options for patients.
Career Highlights
Pekar is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its focus on diabetes care and other therapeutic areas. His work at Eli Lilly has positioned him at the forefront of diabetes research and innovation.
Collaborations
Throughout his career, Pekar has collaborated with esteemed colleagues, including Bruce H Frank and Diane L Bakaysa, contributing to a rich environment of innovation and shared expertise.
Conclusion
Allen H Pekar's work in developing advanced insulin formulations and anti-diabetic compounds underscores his significant impact on diabetes treatment. His contributions continue to shape the future of medical science and improve patient outcomes.